Complexities of oestradiol pharmacology in pulmonary arterial hypertension
P Yuan, L Gao, ZC Jing - European Respiratory Journal, 2013 - Eur Respiratory Soc
We thank SP Tofovic and EK Jackson for their interest in our study [ 1]. It is well known that
pulmonary arterial hypertension (PAH) is a female-predominant disease [ 2–4], and this …
pulmonary arterial hypertension (PAH) is a female-predominant disease [ 2–4], and this …
[PDF][PDF] Oestradiol may exert beneficial effects on the right ventricle, yet may exacerbate PAH and pulmonary vascular lesions. The question of whether oestradiol is …
SP Tofovic, EK Jackson - researchgate.net
We thank SP Tofovic and EK Jackson for their interest in our study [ 1]. It is well known that
pulmonary arterial hypertension (PAH) is a female-predominant disease [ 2–4], and this …
pulmonary arterial hypertension (PAH) is a female-predominant disease [ 2–4], and this …
[引用][C] Complexities of oestradiol pharmacology in pulmonary arterial hypertension
P Yuan, L Gao, ZC Jing - The European respiratory …, 2013 - pubmed.ncbi.nlm.nih.gov
[引用][C] Complexities of oestradiol pharmacology in pulmonary arterial hypertension.
P Yuan, L Gao, ZC Jing - The European Respiratory Journal, 2013 - europepmc.org
This is a comment on" Complexities of oestradiol pharmacology in pulmonary arterial
hypertension." Eur Respir J. 2013 Jun; 41 (6): 1465-6. This is a comment on" Oestradiol …
hypertension." Eur Respir J. 2013 Jun; 41 (6): 1465-6. This is a comment on" Oestradiol …